Karin Kurnik

4.9k total citations
83 papers, 2.5k citations indexed

About

Karin Kurnik is a scholar working on Hematology, Genetics and Internal Medicine. According to data from OpenAlex, Karin Kurnik has authored 83 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 76 papers in Hematology, 17 papers in Genetics and 14 papers in Internal Medicine. Recurrent topics in Karin Kurnik's work include Hemophilia Treatment and Research (43 papers), Blood Coagulation and Thrombosis Mechanisms (39 papers) and Platelet Disorders and Treatments (25 papers). Karin Kurnik is often cited by papers focused on Hemophilia Treatment and Research (43 papers), Blood Coagulation and Thrombosis Mechanisms (39 papers) and Platelet Disorders and Treatments (25 papers). Karin Kurnik collaborates with scholars based in Germany, United Kingdom and Israel. Karin Kurnik's co-authors include Ulrike Nowak‐Göttl, R. Schobeß, Ronald Sträter, Ralf Junker, Christine Heller, Andrea Kosch, Gudrun Günther, W. Kreuz, Achim Heinecke and Arnold von Eckardstein and has published in prestigious journals such as The Lancet, Blood and PLoS ONE.

In The Last Decade

Karin Kurnik

79 papers receiving 2.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Karin Kurnik Germany 26 2.0k 434 406 364 335 83 2.5k
F.R. Rosendaal Netherlands 16 3.2k 1.6× 1.5k 3.5× 862 2.1× 137 0.4× 319 1.0× 23 3.8k
R. Schobeß Germany 23 1.5k 0.8× 625 1.4× 162 0.4× 365 1.0× 315 0.9× 39 1.9k
John K. Wu Canada 22 1.2k 0.6× 576 1.3× 248 0.6× 68 0.2× 333 1.0× 73 1.9k
Katia Paciaroni Italy 18 924 0.5× 460 1.1× 376 0.9× 75 0.2× 125 0.4× 40 1.2k
William L. Nichols United States 29 1.8k 0.9× 252 0.6× 406 1.0× 54 0.1× 552 1.6× 67 2.5k
Serena M. Passamonti Italy 22 637 0.3× 780 1.8× 95 0.2× 134 0.4× 245 0.7× 50 1.6k
Shruti Chaturvedi United States 24 899 0.5× 127 0.3× 505 1.2× 101 0.3× 177 0.5× 101 2.0k
Cindy Neunert United States 23 3.5k 1.8× 144 0.3× 692 1.7× 90 0.2× 606 1.8× 70 4.1k
Bart J. Biemond Netherlands 24 731 0.4× 85 0.2× 672 1.7× 138 0.4× 235 0.7× 67 1.6k
D. Lê Thi Huong France 35 514 0.3× 85 0.2× 178 0.4× 365 1.0× 327 1.0× 82 4.2k

Countries citing papers authored by Karin Kurnik

Since Specialization
Citations

This map shows the geographic impact of Karin Kurnik's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karin Kurnik with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karin Kurnik more than expected).

Fields of papers citing papers by Karin Kurnik

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Karin Kurnik. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karin Kurnik. The network helps show where Karin Kurnik may publish in the future.

Co-authorship network of co-authors of Karin Kurnik

This figure shows the co-authorship network connecting the top 25 collaborators of Karin Kurnik. A scholar is included among the top collaborators of Karin Kurnik based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Karin Kurnik. Karin Kurnik is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Oldenburg, Johannes, Kate Khair, M. G. Mazzucconi, et al.. (2017). Real World Prospective Data on Bleeding Frequency in 1,000 Patients with Hemophilia a - is the Goal of Zero Bleeds Achievable?. Haemophilia. 4 indexed citations
2.
Bidlingmaier, Christoph, Sebastian Hütker, Martin Olivieri, & Karin Kurnik. (2016). Hämostaseologie in der Pädiatrie. Hämostaseologie. 36(2). 109–125. 8 indexed citations
3.
Kenet, Gili, Ulrich C. Klostermeier, Frauke Degenhardt, et al.. (2016). Impact of high risk thrombophilia status on recurrence among children and adults with VTE: An observational multicenter cohort study. Blood Cells Molecules and Diseases. 62. 24–31. 8 indexed citations
4.
Orban, Mathias, Alexander Goedel, Florian Gärtner, et al.. (2015). Functional Comparison of Induced Pluripotent Stem Cell- and Blood-Derived GPIIbIIIa Deficient Platelets. PLoS ONE. 10(1). e0115978–e0115978. 12 indexed citations
5.
Auerswald, Günter, et al.. (2015). The EPIC study: a lesson to learn. Haemophilia. 21(5). 622–628. 27 indexed citations
6.
Klamroth, Robert, Susanne Holzhauer, Rainer Zimmermann, Christine Heller, & Karin Kurnik. (2014). Beriate® P in the treatment of patients with haemophilia A: Results of a long-term pharmacovigilance study. Thrombosis Research. 134. S16–S21. 1 indexed citations
7.
Franke, André, Gili Kenet, Susanne Holzhauer, et al.. (2014). Clinical and laboratory characteristics of paediatric and adolescent index cases with venous thromboembolism and antithrombin deficiency. Thrombosis and Haemostasis. 112(9). 478–485. 24 indexed citations
8.
Kurnik, Karin, et al.. (2014). Climbing therapy under PK-tailored prophylaxis. Hämostaseologie. 34(S 01). S13–S16. 10 indexed citations
9.
Kurnik, Karin, Günter Auerswald, & W. Kreuz. (2013). Inhibitors and prophylaxis in paediatric haemophilia patients: Focus on the German experience. Thrombosis Research. 134. S27–S32. 12 indexed citations
10.
Wahn, V., Werner Aberer, W. Eberl, et al.. (2012). Hereditary angioedema (HAE) in children and adolescents—a consensus on therapeutic strategies. European Journal of Pediatrics. 171(9). 1339–1348. 62 indexed citations
11.
Nowak‐Göttl, Ulrike, Karin Kurnik, Daniela Manner, & Gili Kenet. (2011). Thrombophilia testing in neonates and infants with thrombosis. Seminars in Fetal and Neonatal Medicine. 16(6). 345–348. 8 indexed citations
12.
Kurnik, Karin, et al.. (2007). Meeting Report: Ninth and Tenth Workshops of the European Paediatric Network for Haemophilia Management (PedNet). Haemophilia. 13(5). 658–662. 4 indexed citations
13.
Kurnik, Karin, Frauke Friedrichs, Susan Halimeh, et al.. (2007). Effects of primary and secondary prophylaxis on the clinical expression of joint damage in children with severe haemophilia A. Thrombosis and Haemostasis. 99(1). 71–76. 16 indexed citations
14.
Auerswald, G., M. von Depka Prondzinski, B. Ehlken, et al.. (2004). Treatment patterns and cost‐of‐illness of severe haemophilia in patients with inhibitors in Germany. Haemophilia. 10(5). 499–508. 39 indexed citations
15.
Nowak‐Göttl, Ulrike, Gudrun Günther, Karin Kurnik, Ronald Sträter, & Fenella J. Kirkham. (2003). Arterial Ischemic Stroke in Neonates, Infants, and Children: An Overview of Underlying Conditions, Imaging Methods, and Treatment Modalities. Seminars in Thrombosis and Hemostasis. 29(4). 405–414. 46 indexed citations
16.
Halimeh, Susan, Carmen Escuriola Ettingshausen, Karin Kurnik, et al.. (2002). Symptomatic Onset of severe Hemophilia A in Childhood is dependent on the Presence of Prothrombotic Risk Factors. PubMed. 85(2). 77–80. 84 indexed citations
17.
Till, Holger, et al.. (2001). Multiple intestinal stenoses and peripheral gangrene: A combination of two rare surgical complications in a child with Kawasaki disease. Journal of Pediatric Surgery. 36(4). 651–653. 19 indexed citations
18.
Nowak‐Göttl, Ulrike, Ronald Sträter, Andrea Kosch, et al.. (2001). The plasminogen activator inhibitor (PAI)‐1 promoter 4G/4G genotype is not associated with ischemic stroke in a population of German children. European Journal Of Haematology. 66(1). 57–62. 32 indexed citations
20.
Junker, R., et al.. (2000). Prothrombotic risk factors in children with spontaneous venous thrombosis and their asymptomatic parents: A family study. Neonatology. 78(2). 152. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026